跳至主要内容
临床试验/NL-OMON34554
NL-OMON34554已完成不适用

A multicentre, randomized controlled trial of neurolysis for mild ulnar neuropathy at the elbow - effect of neurolysis for mild ulnar neuropathy at the elbow

Sint Elisabeth Ziekenhuis0 个研究点目标入组 120 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • a. Age 18 years or more.
  • b. Clinical signs of an ulnar neuropathy (i.e., pain, numbness or paraesthesias in the area of the ulnar nerve, weakness or clumsiness of ulnar muscles).
  • c. Duration of symptoms < 9 months.
  • d. MRC sumscore of the flexor carpi ulnaris (FCU), flexor digitorum profundus digiti IV + V (FDP IV-V), abductor digiti minimi (ADM) and first dorsal interosseous I (FDI) muscles > 16 (of a maximum score of 4 x 5 = 20).
  • e. Electrophysiological * or sonographic ** evidence of localization of the lesion at the elbow.
  • f. Informed written consent.

排除标准

  • a. evidence of a coexistent polyneuropathy.
  • b. History of hereditary neuropathy with liability to pressure palsies
  • c. Traumatic origin of UNE.
  • d. Malignancy.
  • e. Previous or current use of chemotherapy.
  • f. Unable to follow up

研究者

发起方
Sint Elisabeth Ziekenhuis

相似试验